About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in New York | 32 Studies

Clinical Trials MigraineNew York

Migraine Clinical Trials in New York

Find 32 clinical trials for migraine near New York, New York. Connect with research centers in your area.

All Migraine trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-32 of 32 trials

RecruitingRandomized Study in Children and Adolescents With Migraine: Acute TreatmentThe purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.NCT04649242·Birmingham, Alabama and 245 others

Migraine Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic MigraineThis study will evaluate safety and tolerability of treatment with atogepant for the prevention of episodic migraine over the course of one year.NCT03700320·Birmingham, Alabama and 111 others

CompletedEfficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan UseThis study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medications due to a previous…NCT05509400·Los Angeles, California and 92 others

CompletedEfficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of MigraineThis study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (50 and 100 mg) compared to placebo for the acute treatment of a single migraine attack.NCT02828020·Mesa, Arizona and 89 others

UnknownThe Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute MigraineThe purpose of this study is to evaluate the efficacy and safety of intra-oral topical ketoprofen for the treatment of acute migraine.NCT01228552·Valhalla, New York

CompletedAn Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of MigraineThis study will evaluate the long-term safety and tolerability of intermittent treatment with ubrogepant for the acute treatment of migraine over 1 year.NCT02873221·Birmingham, Alabama and 176 others

CompletedAn Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine AttackThe purpose of the study is to show the efficacy of a single dose of PRO-513 for treating subjects suffering moderate pain form a migraine attack, with or without aura.NCT00330850·Fairfield, Connecticut and 15 others

CompletedA Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of MigraineStudy STS101-007 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101…NCT04940390·Chandler, Arizona and 126 others

CompletedRandomized Trial in Adult Participants With Acute MigrainesThe purpose of this study is to test the safety and efficacy of BHV-3500 (zavegepant) versus placebo in the acute treatment of moderate or severe migraine.NCT04571060·Huntsville, Alabama and 93 others

CompletedRELAXaHEAD for Headache Patients (Phase I)The goal of this research is to assess the utility of smartphone-based progressive muscle relaxation (PMR) for the treatment of headaches.NCT03183791·New York, New York

CompletedAMG 334 20160172 Pediatric Migraine PK Study.AMG 334 20160172 Pediatric Migraine PK Study.NCT03499119·Little Rock, Arkansas and 13 others

CompletedEvaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 StudyThe main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with episodic migraine.NCT02614183·Tucson, Arizona and 94 others

PreviousPage 2 of 2

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia